The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
Open accessAbstract
Cystic fibrosis (CF) is a fatal genetic disorder associated with defective hydration of lung airways due to the loss of chloride transport through the CF transmembrane conductance regulator protein (CFTR). CFTR contains two membrane-spanning domains (MSDs), two nucleotide-binding domains (NBDs), and a regulatory domain, and its channel assembly requires multiple interdomain contacts. The most common CF-causing mutation, F508del, occurs in NBD1 and results in misfolding and premature degradation of F508del-CFTR. VX-809 is an investigational CFTR corrector that partially restores CFTR function in people who are homozygous for F508del-CFTR. To identify the folding defect(s) in F508del-CFTR that must be repaired to treat CF, we explored the mechanism of VX-809 action. VX-809 stabilized an N-terminal domain in CFTR that contains only MSD1 and efficaciously restored function to CFTR forms that have missense mutations in MSD1. The action of VX-809 on MSD1 appears to suppress folding defects in F508del-CFTR by enhancing interactions among the NBD1, MSD1, and MSD2 domains. The ability of VX-809 to correct F508del-CFTR is enhanced when combined with mutations that improve F508del-NBD1 interaction with MSD2. These data suggest that the use of VX-809 in combination with an additional CFTR corrector that suppresses folding defects downstream of MSD1 may further enhance CFTR function in people with F508del-CFTR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418 · cited 4×
“Fragments of CFTR that contain the N- (1–837) and C- (837–1480) terminus assemble into a complex that folds, escapes the ER, and accumulates as a maturely glycosylated species (Rosser et al., 2008).”
BackgroundMethodInfluentialWebb, A. K. (2006) · Cited by 4,369
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
Rowe, S. M., Miller, S., & Sorscher, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043184 · Cited by 1,398
Demonstration That CFTR Is a Chloride Channel by Alteration of Its Anion Selectivity
Anderson, M. P., Gregory, R. J., Thompson, S., Souza, D. W., Paul, S., Mulligan, R. C., Smith, A. E., & Welsh, M. J. (1991) · Science · doi:10.1126/science.1712984 · Cited by 1,137
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105787108 · Cited by 1,088
Bobadilla, J. L., Macek, M., Fine, J. P., & Farrell, P. M. (2002) · Human Mutation · doi:10.1002/humu.10041 · Cited by 1,032
The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation
Meacham, G. C., Patterson, C., Zhang, W., Younger, J. M., & Cyr, D. M. (2001) · Nature Cell Biology · doi:10.1038/35050509 · Cited by 839
Self-citationChloride impermeability in cystic fibrosis
Quinton, P. M. (1983) · Nature · doi:10.1038/301421a0 · Cited by 767
CFTR Function and Prospects for Therapy
Riordan, J. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142532 · Cited by 610
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice
Castellani, C., Cuppens, H., Macek, M., Cassiman, J. J., Kerem, E., Durie, P., Tullis, E., Assael, B. M., Bombieri, C., Brown, A., et al. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.03.009 · Cited by 601
Pedemonte, N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24898 · Cited by 538
Clancy, J. P., Rowe, S. M., Accurso, F. J., Aitken, M. L., Amin, R. S., Ashlock, M. A., Ballmann, M., Boyle, M. P., Bronsveld, I., Campbell, P. W., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200393 · Cited by 515
Van Goor, F., Straley, K. S., Cao, D., González, J., Hadida, S., Hazlewood, A., Joubran, J., Knapp, T., Makings, L. R., Miller, M., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00169.2005 · Cited by 512
Self-citationYounger, J. M., Chen, L., Ren, H.-Y., Rosser, M. F. N., Turnbull, E. L., Fan, C.-Y., Patterson, C., & Cyr, D. M. (2006) · Cell · doi:10.1016/j.cell.2006.06.041 · Cited by 440
Self-citationLukacs, G. L., Mohamed, A., Kartner, N., Chang, X. B., Riordan, J. R., & Grinstein, S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06954.x · Cited by 396
Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis
Quinton, P. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61162-9 · Cited by 381
Serohijos, A. W. R., Hegedűs, T., Aleksandrov, A. A., He, L., Cui, L., Dokholyan, N. V., & Riordan, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800254105 · Cited by 381
CFTR: folding, misfolding and correcting the ΔF508 conformational defect
Lukacs, G. L., & Verkman, A. S. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.10.003 · Cited by 375
The Hdj‐2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis
Meacham, G. C., Lu, Z., King, S., Sorscher, E., Tousson, A., & Cyr, D. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1492 · Cited by 335
Self-citationRabeh, W. M., Bossard, F., Xu, H., Okiyoneda, T., Bagdany, M., Mulvihill, C. M., Du, K., di Bernardo, S., Liu, Y., Konermann, L., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.024 · Cited by 280
Cystic fibrosis: a disease of vulnerability to airway surface dehydration
Boucher, R. C. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.05.001 · Cited by 273
Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences
Mendoza, J. L., Schmidt, A., Li, Q., Nuvaga, E., Barrett, T., Bridges, R. J., Feranchak, A. P., Brautigam, C. A., & Thomas, P. J. (2012) · Cell · doi:10.1016/j.cell.2011.11.023 · Cited by 261
Domain Interdependence in the Biosynthetic Assembly of CFTR
Cui, L., Aleksandrov, L., Chang, X.-B., Hou, Y.-X., He, L., Hegedus, T., Gentzsch, M., Aleksandrov, A., Balch, W. E., & Riordan, J. R. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.086 · Cited by 216
Farinha, C. M., & Amaral, M. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.5242-5252.2005 · Cited by 201
Teem, J. L., Berger, H. A., Ostedgaard, L. S., Rich, D. P., Tsui, L.-C., & Welsh, M. J. (1993) · Cell · doi:10.1016/0092-8674(93)90233-g · Cited by 179
Mornon, J., Lehn, P., & Callebaut, I. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8249-1 · Cited by 163
He, L., Kota, P. B., Aleksandrov, A. A., Cui, L., Jensen, T., Dokholyan, N. V., & Riordan, J. R. (2012) · The FASEB Journal · doi:10.1096/fj.12-216119 · Cited by 155
Cooperative Assembly and Misfolding of CFTR Domains In Vivo
Du, K., & Lukacs, G. L. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-09-0950 · Cited by 147 · cited 1×
“Volume 24 October 1, 2013 Correction of CFTR misfolding | 3017 Okiyoneda et al., 2004; Farinha and Amaral, 2005; Lukacs and Verkman, 2012); identify defective interactions between MSD1, NBD1, and MSD2 as an underlying cause of premature degradation of F508del-CFTR (Younger et al., 2006; Cui et al.,…”
BackgroundMechanisms of CFTR Folding at the Endoplasmic Reticulum
Kim, S. J., & Skach, W. R. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00201 · Cited by 142
Lewis, H. A., Wang, C., Zhao, X., Hamuro, Y., Conners, K., Kearins, M. C., Lu, F., Sauder, J. M., Molnar, K. S., Coales, S. J., et al. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.11.051 · Cited by 141
Wang, Y., Loo, T. W., Bartlett, M. C., & Clarke, D. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700175200 · Cited by 134
Grove, D. E., Fan, C., Ren, H. Y., & Cyr, D. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-09-0760 · Cited by 133
Self-citationCsanády, L., Chan, K. W., Seto‐Young, D., Kopsco, D. C., Nairn, A. C., & Gadsby, D. C. (2000) · The Journal of General Physiology · doi:10.1085/jgp.116.3.477 · Cited by 127
ΔF508 CFTR Pool in the Endoplasmic Reticulum Is Increased by Calnexin Overexpression
Okiyoneda, T., Harada, K., Takeya, M., Yamahira, K., Wada, I., Shuto, T., Suico, M. A., Hashimoto, Y., & Kai, H. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-06-0379 · Cited by 107
Wang, C., Protasevich, I. I., Yang, Z. W., Seehausen, D., Skalak, T. J., Zhao, X., Atwell, S., Emtage, J. S., Wetmore, D. R., Brouillette, C. G., et al. (2010) · Protein Science · doi:10.1002/pro.480 · Cited by 104
Rosser, M. F. N., Grove, D. E., Chen, L., & Cyr, D. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-04-0357 · Cited by 100
Self-citationRescuing Mutant CFTR: A Multi-task Approach to a Better Outcome in Treating Cystic Fibrosis
Amaral, M. D., & Farinha, C. M. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990318 · Cited by 96
Pissarra, L. S., Farinha, C. M., Xu, Z., Schmidt, A., Thibodeau, P. H., Cai, Z., Thomas, P., Sheppard, D. N., & Amaral, M. D. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.012 · Cited by 86
Goor, F. V., Yu, H. D., Burton, B., Huang, C.-J., Hoffman, B. J., Cao, H., Machuca, T., Yeung, J. C., Bonato, R., Duan, C., et al. (2012) · Cited by 76
Self-citationMoniz, S., Sousa, M., Moraes, B. J., Mendes, A. I., Palma, M., Barreto, C., Fragata, J., Amaral, M. D., & Matos, P. (2012) · ACS Chemical Biology · doi:10.1021/cb300484r · Cited by 68
Cyr, D. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0105-2 · Cited by 37
Self-citationIncreased folding and channel activity of a rare cystic fibrosis mutant with CFTR modulators
Caldwell, R. A., Grove, D. E., Houck, S. A., & Cyr, D. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00044.2011 · Cited by 17
Self-citation
Cited by
Veit, G., Avramescu, R. G., Chiang, A. N., Houck, S. A., Cai, Z., Peters, K. W., Hong, J. S., Pollard, H. B., Guggino, W. B., Balch, W. E., et al. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0935 · Cited by 580
Self-citationCFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lopes-Pacheco, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01662 · Cited by 535
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
Cholon, D. M., Quinney, N. L., Fulcher, M. L., Esther, C. R., Das, J., Dokholyan, N. V., Randell, S. H., Boucher, R. C., & Gentzsch, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008680 · Cited by 320
Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression
Veit, G., Avramescu, R. G., Perdomo, D., Phuan, P.-W., Bagdany, M., Apaja, P. M., Borot, F., Szollosi, D., Wu, Y.-S., Finkbeiner, W. E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008889 · Cited by 287
Small-Molecule Modulation of Protein Homeostasis
Burslem, G. M., & Crews, C. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00077 · Cited by 283
Metadata
- Authors
- Ren, H. Y., Grove, D. E., De La Rosa, O., Houck, S. A., Sopha, P., Van Goor, F., Hoffman, B. J., & Cyr, D. M.
- Venue
- Molecular Biology of the Cell
- Published
- 2013-10
- Volume
- 24
- Issue
- 19
- Pages
- 3016-3024
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- OpenAlex
- W1998953032
- Cited by
- 284
- References
- 43
- FWCI
- 18.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.